Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients

Fig. 5

Validation of the mass spectrometry results. a Immunoblotting for the major proteins, HSP71, HMOX1, and ANX-A6 in a representative PE-DBMSCs (placenta numbers 43 and 62) as compared to the normal DBMSCs (placenta numbers 37 and 58), respectively. Beta actin is the loading control. b RT-PCR analysis of HMOX1 in a subset of PE-DBMSCs as compared to the normal PE-DBMSCs (numbers represent the placenta number tested). Data is represented as ΔcT (absolute expression) as compared with control. Experiments were conducted in triplicate using cells prepared from five placentae. Bars represent standard errors

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512